Creso Pharma Ltd: LOI to Import MDMA & Psilocybin Treatments to Australia
Creso Pharma Ltd: Mernova Appoints CannDelta to Map EU GMP Export Process
Creso Pharma Ltd: Mernova Q2 Sales Update
Creso Pharma Ltd: Trading Halt
Creso Pharma Ltd: Response to Financial Condition Query
Creso Pharma Ltd: Creso Pharma Expands Asia Market Footprint
Creso Pharma Ltd: Response to ASX Price Query
Creso Pharma Ltd: Sierra Sage Herbs LLC Update
Creso Pharma Ltd: Halucenex Phase II Clinical Trial Update
Creso Pharma Ltd: Mernova - Eighth Province Entry & $553k in New POs
Creso Pharma Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Creso Pharma Ltd: Mernova - Q1 Cashflow Positive With Record Revenues
Creso Pharma Ltd: ASX Listing Rule 3.13.1 Notice Regarding AGM
Creso Pharma Ltd: Appendix 4G and Corporate Governance Statement
Creso Pharma Ltd: Censure of Creso Pharma Limited
Creso Pharma Ltd: $2.5M Con Note Issue, Rollover & Extinguishment of Debt
Creso Pharma Ltd: Trading Halt
Creso Pharma Ltd: Restricted Securities to be Released from Escrow
Creso Pharma Ltd: Creso reports strong progress across business units
Creso Pharma Ltd: Halucenex to pursue AUS entry after landmark TGA decision
No Data